NanoAssemblr Spark: microliter-scale nanomedicine formulation discovery and screening 

In this video we demonstrate the NanoAssemblr Spark: ideal for accelerating screening
workflows for the identification
of novel LNPs for biological
applications.
The NanoAssemblr Spark has an operating nanoparticle formulation volume of 25 - 250 μL.
By ensuring yields nearing 100%, the Spark is ideal for target validation screening and nanoparticle formulation development that involves scarce or expensive nucleic acid constructs and nanoparticle excipients.
Contact us today to request a quote or learn more at www.cytiva.com